ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.020,49
0,00%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,06999
-0,16%
Bitcoin
66.091,59
-0,82%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. ETFs
  4. Kanada
  5. TSX
  6. iShares S&P TSX Canadian Preferred Share Index ETF (CPD)

  7. iShares S&P TSX Canadian Preferred Share Index ETF (CPD) News

CPD

iShares S&P TSX Canadian... (CPD)

iShares S&P TSX Canadian Preferred Share Index ETF
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSX:CPD
DatumZeitQuelleÜberschriftSymbolFirma
15/11/201211h00Marketwired CanadaCanadian Zinc Reports Financial and Operating Results for Third Quarter 2012TSX:CPDiShares S&P TSX Canadian Preferred Share Index ETF
16/05/201212h00Marketwired CanadaCanadian Zinc Reports Financial Results for First Quarter 2012TSX:CPDiShares S&P TSX Canadian Preferred Share Index ETF
28/01/201023h43PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010AMEX:CPD
18/11/200916h20PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Nicardipine Hydrochloride InjectionAMEX:CPD
06/11/200916h36PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic SolutionAMEX:CPD
06/11/200915h53PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic SolutionAMEX:CPD
27/10/200916h59PR Newswire (US)/C O R R E C T I O N -- Caraco Pharmaceutical Laboratories, Ltd./AMEX:CPD
27/10/200914h13PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010AMEX:CPD
02/10/200915h05PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (esAMEX:CPD
29/09/200922h01PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing OperationsAMEX:CPD
23/09/200923h00PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of DirectorsAMEX:CPD
15/09/200915h08PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Appointment of F. Folsom Bell to Board of DirectorsAMEX:CPD
27/08/200916h34PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Reversal of Summary Judgment in Ultracet(R) ANDA Patent LitigationAMEX:CPD
12/08/200900h37PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Imitrex(R) TabletsAMEX:CPD
03/08/200906h22PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Settlement of Ethyol(R) ANDA Patent LitigationAMEX:CPD
29/07/200901h30PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as Jitendra N. Doshi Assumes Position of CEOAMEX:CPD
28/07/200922h42PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010AMEX:CPD
24/07/200901h01PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Filing of Purported Class Action LawsuitsAMEX:CPD
10/07/200915h15PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(RAMEX:CPD
07/07/200917h44PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) TabletsAMEX:CPD
06/07/200915h04PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its WorkforceAMEX:CPD
26/06/200915h15PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial PositionAMEX:CPD
26/06/200904h09PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces FDA ActionAMEX:CPD
29/05/200901h51PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year 2009, Updates on FDA InspectionAMEX:CPD
14/05/200916h24PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Roxicodone(R) TabletsAMEX:CPD
02/04/200916h03PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Topamax(R) TabletsAMEX:CPD
31/03/200920h50PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces a Nationwide Voluntary Recall of All Lots of Digoxin Tablets Due to Size VariAMEX:CPD
29/01/200916h41PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009AMEX:CPD
22/01/200915h24PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. to Announce Third Quarter of Fiscal Year 2009 Results on January 29, 2009AMEX:CPD
25/11/200802h00PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Responds to FDA Warning LetterAMEX:CPD
 Showing the most relevant articles for your search:TSX:CPD

Kürzlich von Ihnen besucht

NASDAQ
QQQ
Invesco QQQ Trust Series 1
DBI
TDXP
Tec DAX
TG
432
Arbor Metals
USOTC
BNPQY
BNP Paribas (QX)
TG
BAYN
Bayer
NASDAQ
NVDA
NVIDIA
NASDAQ
AAPL
Apple
TG
MBG
MercedesBenz
TG
NOV
Novo Nordisk
TG
BAS
BASF
AMEX
SPY
SPDR S&P 500
FX
EURUSD
Euro vs US Dollar
NYSE
KO
Coca Cola
COIN
ETHUSD
Ethereum
AMEX
XLF
Financial Select Sector
DBI
DAX
DAX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten